Establishment and characterization of Prnp knock-down neuroblastoma cells using dual microRNA-mediated RNA interference

Prion

Volumn 5, Issue 2, 2011, Pages 93-102

  Kang, Sang Gyun ^a,b   Roh, Yu Mi ^a   Lau, Agnes ^b   Westaway, David ^b   McKenzie, Debbie ^b   Aiken, Judd ^b   Kim, Yong Sun ^c   Yoo, Han Sang ^a  

^a Seoul National University   (South Korea)

^b UNIVERSITY OF ALBERTA   (Canada)

^c Hallym University   (South Korea)

Author keywords

miRNA; N2a; Prnp; PrP C; RNAi

Indexed keywords

MICRORNA; PRION PROTEIN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; GENE EXPRESSION; NEUROBLASTOMA CELL; PATHOGENESIS; PRION DISEASE; RNA INTERFERENCE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; MICE; MICRORNAS; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; PRIONS; RNA INTERFERENCE;

EID: 79959485215     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.5.2.15621     Document Type: Article

References (58)

1. Sutou S, Kunishi M, Kudo T, Wongsrikeao P, Miyagishi M, Otoi T Knockdown of the bovine prion gene PRNP by RNA interference (RNAi) technology. BMC Biotechnol 2007; 7:44.
2. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363-83.
3. Basier K, Oesch B, Scott M, Westaway D, Walchli M, Groth DF, et al. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 1986; 46:417-28. (Pubitemid 16031678)
4. Trevitt CR, Collinge J. A systematic review of prion therapeutics in experimental models. Brain 2006; 129:2241-65. (Pubitemid 44522112)
5. Nuvolone M, Aguzzi A, Heikenwalder M. Cells and prions: a license to replicate. FEBS Lett 2009; 583:2674-84.
6. Aguzzi A, Heikenwalder M. Prion diseases: Cannibals and garbage piles. Nature 2003; 423:127-9. (Pubitemid 36569522)
7. White MD, Mallucci GR. Therapy for prion diseases: Insights from the use of RNA interference. Prion 2009; 3:121-8.
8. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992; 356:577-82.
9. Nico PB, de-Paris F, Vinade ER, Amaral OB, Rockenbach I, Soares BL, et al. Altered behavioural response to acute stress in mice lacking cellular prion protein. Behav Brain Res 2005; 162:173-81.
10. Milhavet O, Casanova D, Chevallier N, McKay RD, Lehmann S. Neural stem cell model for prion propagation. Stem Cells 2006; 24:2284-91.
11. Beranger F, Mange A, Solassol J, Lehmann S. Cell culture models of transmissible spongiform encephalopathies. Biochem Biophys Res Commun 2001; 289:311-6. (Pubitemid 33141054)
12. Mittal V. Improving the efficiency of RNA interference in mammals. Nat Rev Genet 2004; 5:355-65. (Pubitemid 38529407)
13. Aguzzi A, Sigurdson C, Heikenwaelder M. Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 2008; 3:11-40.
14. Zomosa-Signoret V, Arnaud JD, Fontes P, Alvarez-Martinez MT, Liautard JP. Physiological role of the cellular prion protein. Vet Res 2008; 39:9.
15. Aguzzi A, Heikenwalder M. Pathogenesis of prion diseases: current status and future outlook. Nat Rev Microbiol 2006; 4:765-75. (Pubitemid 44420127)
16. Mallucci G, Collinge J. Rational targeting for prion therapeutics. Nat Rev Neurosci 2005; 6:23-34.
17. Spray DC, Iacobas DA. Organizational principles of the connexin-related brain transcriptome. J Membr Biol 2007; 218:39-47. (Pubitemid 350132122)
18. Insel PA, Patel HH. Do studies in caveolin-knockouts teach us about physiology and pharmacology or instead, the ways mice compensate for 'lost proteins'? Br J Pharmacol 2007; 150:251-4. (Pubitemid 46221032)
19. Kim VN. Small RNAs: classification, biogenesis and function. Mol Cells 2005; 19:1-15.
20. Cullen BR. Enhancing and confirming the specificity of RNAi experiments. Nat Methods 2006; 3:677-81. (Pubitemid 44275733)
21. Whangbo JS, Hunter CP. Environmental RNA interference. Trends Genet 2008; 24:297-305.
22. Clark J, Ding S. Generation of RNAi Libraries for High-Throughput Screens. J Biomed Biotechnol 2006; 2006:45716.
23. Vilette D, Andreoletti O, Archer F, Madelaine MF, Vilotte JL, Lehmann S, et al. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc Natl Acad Sci USA 2001; 98:4055-9. (Pubitemid 32249897)
24. C offset pro-apoptotic activity of the Doppel helix B/B' region. J Biol Chem 2004; 279:55443-54. (Pubitemid 40066545)
25. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004; 23:4051-60. (Pubitemid 39472426)
26. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003; 115:787-98. (Pubitemid 38058492)
27. Detrait ER, Bowers WJ, Halterman MW, Giuliano RE, Bennice L, Federoff HJ, et al. Reporter gene transfer induces apoptosis in primary cortical neurons. Mol Ther 2002; 5:723-30. (Pubitemid 34619065)
28. Liu HS, Jan MS, Chou CK, Chen PH, Ke NJ. Is green fluorescent protein toxic to the living cells? Biochem Biophys Res Commun 1999; 260:712-7.
29. Torbett BE. Reporter genes: too much of a good thing? J Gene Med 2002; 4:478-9.
30. Satoh J, Obayashi S, Misawa T, Sumiyoshi K, Oosumi K, Tabunoki H. Protein microarray analysis identifies human cellular prion protein interactors. Neuropathol Appl Neurobiol 2009; 35:16-35.
31. Satoh J, Yamamura T. Gene expression profile following stable expression of the cellular prion protein. Cell Mol Neurobiol 2004; 24:793-814. (Pubitemid 40174230)
32. Meggio F, Negro A, Sarno S, Ruzzene M, Bertoli A, Sorgato MC, et al. Bovine prion protein as a modulator of protein kinase CK2. Biochem J 2000; 352:191-6.
33. Dong CF, Wang XF, Wang X, Shi S, Wang GR, Shan B, et al. Molecular interaction between prion protein and GFAP both in native and recombinant forms in vitro. Med Microbiol Immunol 2008; 197:361-8.
34. Archangelo LF, Greif PA, Holzel M, Harasim T, Kremmer E, Przemeck GK, et al. The CALM and CALM/AF10 interactor CATS is a marker for proliferation. Mol Oncol 2008; 2:356-67.
35. Zimmerman WC, Erikson RL. Polo-like kinase 3 is required for entry into S phase. Proc Natl Acad Sci USA 2007; 104:1847-52. (Pubitemid 46239867)
36. Conn CW, Hennigan RF, Dai W, Sanchez Y, Stambrook PJ. Incomplete cytokinesis and induction of apoptosis by overexpression of the mammalian polo-like kinase, Plk3. Cancer Res 2000; 60:6826-31. (Pubitemid 32059146)
37. Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 2008; 88:673-728.
38. Knott AB, Perkins G, Schwarzenbacher R, Bossy-Wetzel E. Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 2008; 9:505-18.
39. Dagda RK, Merrill RA, Cribbs JT, Chen Y, Hell JW, Usachev YM, et al. The spinocerebellar ataxia 12 gene product and protein phosphatase 2A regulatory subunit Bbeta2 antagonizes neuronal survival by promoting mitochondrial fission. J Biol Chem 2008; 283:36241-8.
40. Litchfield DW. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem J 2003; 369:1-15. (Pubitemid 36174119)
41. Chen J, Gao C, Shi Q, Wang G, Lei Y, Shan B, et al. Casein kinase II interacts with prion protein in vitro and forms complex with native prion protein in vivo. Acta Biochim Biophys Sin (Shanghai) 2008; 40:1039-47.
42. Heriche JK, Lebrin F, Rabilloud T, Leroy D, Chambaz EM, Goldberg Y. Regulation of protein phosphatase 2A by direct interaction with casein kinase 2alpha. Science 1997; 276:952-5. (Pubitemid 27209094)
43. Kisby GE, Lesseiroth H, Olivas A, Samson L, Gold B, Tanaka K, et al. Role of nucleotide- and base-excision repair in genotoxin-induced neuronal cell death. DNA Repair (Amst) 2004; 3:617-27. (Pubitemid 38609051)
44. Kisby GE, Olivas A, Park T, Churchwell M, Doerge D, Samson LD, et al. DNA repair modulates the vulnerability of the developing brain to alkylating agents. DNA Repair (Amst) 2009; 8:400-12.
45. C) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis. Proc Natl Acad Sci USA 2006; 103:3416-21. (Pubitemid 43346483)
46. Wu G, Nakajima K, Takeyama N, Yukawa M, Taniuchi Y, Sakudo A, et al. Species-specific anti-apoptotic activity of cellular prion protein in a mouse PrP-deficient neuronal cell line transfected with mouse, hamster and bovine Prnp. Neurosci Lett 2008; 446:11-5.
47. Anantharam V, Kanthasamy A, Choi CJ, Martin DP, Latchoumycandane C, Richt JA, et al. Opposing roles of prion protein in oxidative stress- and ER stress-induced apoptotic signaling. Free Radic Biol Med 2008; 45:1530-41.
48. C) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation. Brain Res Mol Brain Res 2004; 124:40-50. (Pubitemid 38496272)
49. Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, Catez F, et al. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell 2001; 1:515-25. (Pubitemid 33586103)
50. Breckenridge DG, Stojanovic M, Marcellus RC, Shore GC. Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol. J Cell Biol 2003; 160:1115-27. (Pubitemid 36443879)
51. Abu-Qare AW, Abou-Donia MB. Biomarkers of apoptosis: release of cytochrome c, activation of caspase-3, induction of 8-hydroxy-2′- deoxyguanosine, increased 3-nitrotyrosine and alteration of p53 gene. J Toxicol Environ Health B Crit Rev 2001; 4:313-32. (Pubitemid 32701729)
52. Shigemura N, Kiyoshima T, Sakai T, Matsuo K, Momoi T, Yamaza H, et al. Localization of activated caspase-3-positive and apoptotic cells in the developing tooth germ of the mouse lower first molar. Histochem J 2001; 33:253-8. (Pubitemid 32807973)
53. Gottlieb RA, Granville DJ. Analyzing mitochondrial changes during apoptosis. Methods 2002; 26:341-7.
54. Li K, Li Y, Shelton JM, Richardson JA, Spencer E, Chen ZJ, et al. Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis. Cell 2000; 101:389-99.
55. McBride JL, Boudreau RL, Harper SQ, Staber PD, Monteys AM, Martins I, et al. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci USA 2008; 105:5868-73. (Pubitemid 351758464)
56. Kang SG, Roh YM, Kang ML, Kim YS, Yoo HS. Mouse neuronal cells expressing exogenous bovine PRNP and simultaneous downregulation of endogenous mouse PRNP using siRNAs. Prion 4:32-7.
57. Smith C. Sharpening the tools of RNA interference. Natuer Methods 2006; 3:475-86. (Pubitemid 43811560)
58. Choi JK, Park SJ, Jun YC, Oh JM, Jeong BH, Lee HP, et al. Generation of monoclonal antibody recognized by the GXXXG motif (glycine zipper) of prion protein. Hybridoma (2005) 2006; 25:271-7.